Colinz Laboratories
Colinz Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Colinz Laboratories
Start SIPColinz Laboratories Investment Rating
-
Master Rating:
-
Colinz Laboratories has an operating revenue of Rs. 7.02 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 7% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 83 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 2 | 2 | 2 | 2 |
| Operating Expenses Qtr Cr | 2 | 2 | 2 | 1 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 |
Colinz Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 38.37
- 50 Day
- 40.22
- 100 Day
- 41.63
- 200 Day
- 39.98
- 20 Day
- 37.82
- 50 Day
- 40.68
- 100 Day
- 44.25
- 200 Day
- 41.41
Colinz Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 38.02 |
| Second Resistance | 40.03 |
| Third Resistance | 41.66 |
| RSI | 36.31 |
| MFI | 62.94 |
| MACD Single Line | -0.75 |
| MACD | -0.75 |
| Support | |
|---|---|
| First Resistance | 34.38 |
| Second Resistance | 32.75 |
| Third Resistance | 30.74 |
Colinz Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 461 | 46,100 | 100 |
| Week | 366 | 36,580 | 100 |
| 1 Month | 368 | 36,795 | 100 |
| 6 Month | 1,861 | 186,112 | 100 |
Colinz Laboratories Result Highlights
Colinz Laboratories Synopsis
BSE-Medical-Generic Drugs
Colinz Laborator belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 6.97 Cr. and Equity Capital is Rs. 3.55 Cr. for the Year ended 31/03/2022. Colinz Laboratories Ltd. is a Public Limited Listed company incorporated on 06/10/1986 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1986PLC041128 and registration number is 041128.| Market Cap | 9 |
| Sales | 7 |
| Shares in Float | 0.09 |
| No of funds | 1 |
| Yield |
| Book Value | 1.66 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | 0.24 |
| Beta | 0.59 |
Colinz Laboratories
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Apr-22 |
|---|---|---|---|---|
| Promoters | 66% | 65.93% | 66.01% | |
| Financial Institutions/ Banks | 0.12% | 0.12% | 0.12% | |
| Individual Investors | 31.81% | 31.84% | 31.81% | |
| Others | 2.07% | 2.11% | 2.06% |
Colinz Laboratories Management
| Name | Designation |
|---|---|
| Mr. N K Menon | Whole Time Director |
| CA. Vasant K Bhat | Independent Director |
| Mr. A Krishna Kumar | Independent Director |
| Dr. Mani L S | Director |
Colinz Laboratories Forecast
Price Estimates
Colinz Laboratories FAQs
What is Share Price of Colinz Laboratories ?
Colinz Laboratories share price is ₹34 As on 29 March, 2023 | 15:30
What is the Market Cap of Colinz Laboratories ?
The Market Cap of Colinz Laboratories is ₹8.7 Cr As on 29 March, 2023 | 15:30
What is the P/E ratio of Colinz Laboratories ?
The P/E ratio of Colinz Laboratories is 21.7 As on 29 March, 2023 | 15:30
What is the PB ratio of Colinz Laboratories ?
The PB ratio of Colinz Laboratories is 1.1 As on 29 March, 2023 | 15:30